ATOLTIVIMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Mon Mar 31 23:11:32 GMT 2025` Edited by `admin` on `Mon Mar 31 23:11:32 GMT 2025`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	FJZ07Q63VY
Record Status	`Validated (UNII)`
Record Version

Download

Related Record	Type

Name

Type

Language

ATOLTIVIMAB

Official Name

English

REGN3470

Preferred Name

English

REGN-3470

Common Name

English

IMMUNOGLOBULIN G1-KAPPA, ANTI-(ZAIRE EBOLAVIRUS (ZAIRE EBOLA VIRUS (EBOV)) ENVELOPE GLYCOPROTEIN (GP)), HOMO SAPIENS MONOCLONAL ANTIBODYGAMMA1 HEAVY CHAIN HOMO SAPIENS (1-446) (VH (HOMO SAPIENS IGHV3-33*01 (94.9%)-(IGHD)-IGHJ4*01 (100%)) (8.8.9) (1-116)-

Systematic Name

English

IMMUNOGLOBULIN G1, ANTI-(ZAIRE EBOLAVIRUS GLYCOPROTEIN) (HUMAN MONOCLONAL REGN3470 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN3470 .KAPPA.-CHAIN, DIMER

Systematic Name

English

Atoltivimab [WHO-DD]

Common Name

English

atoltivimab [INN]

Common Name

English

ATOLTIVIMAB [USAN]

Common Name

English

REGN-EB3 COMPONENT ATOLTIVIMAB

Common Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

714619

Created by admin on Mon Mar 31 23:11:32 GMT 2025 , Edited by admin on Mon Mar 31 23:11:32 GMT 2025

FDA ORPHAN DRUG

536316

Created by admin on Mon Mar 31 23:11:32 GMT 2025 , Edited by admin on Mon Mar 31 23:11:32 GMT 2025

Code System Code Type Description

RXCUI

2461338

Created by admin on Mon Mar 31 23:11:32 GMT 2025 , Edited by admin on Mon Mar 31 23:11:32 GMT 2025

PRIMARY

CAS

2135632-29-8

Created by admin on Mon Mar 31 23:11:32 GMT 2025 , Edited by admin on Mon Mar 31 23:11:32 GMT 2025

PRIMARY

SMS_ID

300000004884

Created by admin on Mon Mar 31 23:11:32 GMT 2025 , Edited by admin on Mon Mar 31 23:11:32 GMT 2025

PRIMARY

DAILYMED

FJZ07Q63VY

Created by admin on Mon Mar 31 23:11:32 GMT 2025 , Edited by admin on Mon Mar 31 23:11:32 GMT 2025

PRIMARY

WIKIPEDIA

Atoltivimab

Created by admin on Mon Mar 31 23:11:32 GMT 2025 , Edited by admin on Mon Mar 31 23:11:32 GMT 2025

PRIMARY

USAN

FG-87

Created by admin on Mon Mar 31 23:11:32 GMT 2025 , Edited by admin on Mon Mar 31 23:11:32 GMT 2025

PRIMARY

NCI_THESAURUS

C169793

Created by admin on Mon Mar 31 23:11:32 GMT 2025 , Edited by admin on Mon Mar 31 23:11:32 GMT 2025

PRIMARY

INN

11032

Created by admin on Mon Mar 31 23:11:32 GMT 2025 , Edited by admin on Mon Mar 31 23:11:32 GMT 2025

PRIMARY

FDA UNII

FJZ07Q63VY

Created by admin on Mon Mar 31 23:11:32 GMT 2025 , Edited by admin on Mon Mar 31 23:11:32 GMT 2025

PRIMARY

From	To
2_219	4_215
1_219	3_215
1_22	1_96
1_143	1_199
1_260	1_320
1_366	1_424
2_22	2_96
2_143	2_199
2_260	2_320
2_366	2_424
3_23	3_88
3_135	3_195
4_23	4_88
4_135	4_195
1_225	2_225
1_228	2_228

Glycosylation Type

MAMMALIAN

Glycosylation Link Type	Site
N	1_296
N	2_296

Related Record Type Details


					3R8G5WNW24

ZAIRE EBOLAVIRUS

TARGET ORGANISM->INHIBITOR

Amount:

ATOLTIVIMAB-EBGN

SUB_CONCEPT->SUBSTANCE

Amount:

Related Record Type Details


					FJZ07Q63VY

ACTIVE MOIETY

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Molecular Formula	CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL